Harvard, MIT, Cambridge, Brown & Northwestern Universities trained team leverages proprietary transomics translation technology to open a new era of drug discovery, rediscovery, and rescue.
Pepper Bio, the world’s first transomics drug discovery company, emerges from stealth today to leverage its proprietary transomics — including phosphoproteomics — data translation technology to discover new drugs, rediscover new uses for existing therapeutics, and rescue drugs that may be on a course toward failing.
Read on for the full press release.
Source: WebWire // See original post here.